Skip to main content
Explore URMC
menu

David M. Dobrzynski, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-0526

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Hospital Medicine, Infectious Diseases

Biography

Professional Background

Dr. Dobrzynski received his Bachelor of Science in Biochemistry from Bucknell University and his Doctorate of Medicine from Albany Medical College. He completed his Internal Medicine Residency at Wake Forest Baptist Medical Center(WFBMC) in Winston-Salem, NC. He continued on as faculty at WFBMC as an Assistant Chief of Medicine for the following year. He then went on to complete his Infectious Diseases Fellowship at Vanderbilt University in Nashville, TN.
He currently sees inpatients on the General Infectious Diseases consult service as well as outpatients in the general ID Clinic. He also serves as Program Director of the Infectious Diseases Fellowship Program and Medical Director for the Antimicrobial Stewardship Program at Strong Memorial Hospital.

Research

His main clinical research interests include respiratory viral infections, COVID-19 therapeutics, antimicrobial stewardship, multi-drug resistant organisms, and hospital-acquired infections. He also remains active in teaching of fellows, residents, and medical students.

Credentials

Specialties

  • Infectious Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

2012
MD | Albany Medical College of Union University

Post-doctoral Training & Residency

07/01/2016 - 06/30/2018
Fellowship in Infectious Disease at Vanderbilt University Medical Center

06/24/2013 - 06/23/2015
Residency in Internal Medicine at Wake Forest University Baptist Medical Center-Radiology

06/24/2012 - 06/23/2013
Internship in Internal Medicine at Wake Forest University Baptist Medical Center-Radiology

VIEW ALL expand_more

Publications

Journal Articles

10/21/2022
Debnath A, Pillinger KE, Martin AJ, Dobrzynski D, Cameron A, Shulder S. "Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections." The Annals of pharmacotherapy.. 2022 Oct 21; :10600280221132019. Epub 2022 Oct 21.

6/20/2022
Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, Paul Chourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Archer JI, Crandon S, Zemanek JA, Brown ER, Neuzil KM, Stephens DS, Post DJ, Nayak SU, Suthar MS, Roberts PC, Beigel JH, Montefiori DC, . "Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant." Cell reports. Medicine.. 2022 Jun 20; :100679. Epub 2022 Jun 20.

1/26/2022
Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH, . "Homologous and Heterologous Covid-19 Booster Vaccinations." The New England journal of medicine.. 2022 Jan 26; Epub 2022 Jan 26.

VIEW ALL PUBLICATIONS